Abstract
Background
The “Small-for-Size” syndrome is defined as a liver failure after a liver transplant with a reduced graft or after a major hepatectomy. The later coined “Small-for-Flow” syndrome describes the same situation in liver resections but based on hemodynamic intraoperative parameters (portal pressure > 20 mmHg and/or portal flow > 250 ml/min/100 g). This focuses on the damage caused by the portal hyperafflux related to the volume of the remnant.
Methods
Relevant studies were reviewed using Medline, PubMed, and Springer databases.
Results
Portal hypertension after partial hepatectomies also leads to a higher morbidity and mortality. There are plenty of experimental studies focusing on flow rather than size. Some of them also perform different techniques to modulate the portal inflow. The deleterious effect of high posthepatectomy portal venous pressure is known, and that is why the idea of portal flow modulation during major hepatectomies in humans is increasing in everyday clinical practice.
Conclusions
Considering the extensive knowledge obtained with the experimental models and good results in clinical studies that analyze the “Small-for-Flow” syndrome, we believe that measuring portal flow and portal pressure during major liver resections should be performed routinely in extended liver resections. Applying these techniques, the knowledge of hepatic hemodynamics would be improved in order to advance against posthepatectomy liver failure.
Similar content being viewed by others
Abbreviations
- ALPPS:
-
Associating liver partition and portal vein ligation for staged hepatectomy
- HSCs:
-
Hematopoietic stem cells
- IRI:
-
Ischemia-reperfusion injury
- PHLF:
-
Posthepatectomy liver failure
- PIM:
-
Portal inflow modulation
- PVE:
-
Portal vein embolization
- PVP:
-
Portal venous pressure
- SFFS:
-
Small-for-Flow syndrome
- SFSS:
-
Small-for-Size syndrome
- VLR:
-
Volume liver remnant
References
Starzl TE, Putnam CW, Groth CG, Corman JL, Taubman J. Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg. mayo de 1975;129(5):587–90.
Hibi T, Kitagawa Y. Small-for-size syndrome in LT: Small-for-Size Syndrome in LT. Clin Liver Dis. octubre de 2017;10(4):93–6.
Bell R, Pandanaboyana S, Upasani V, Prasad R. Impact of graft-to-recipient weight ratio on small-for-size syndrome following living donor liver transplantation: Small-for-size grafts in LDLT. ANZ J Surg. mayo de 2018;88(5):415–20.
Kaido T, Mori A, Ogura Y, Hata K, Yoshizawa A, Iida T, et al. Lower limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver transplantation in combination with portal pressure control. Transplant Proc. julio de 2011;43(6):2391–3.
Fiorentini G, Sarti D, Aliberti C, Carandina R, Mambrini A, Guadagni S. Multidisciplinary approach of colorectal cancer liver metastases. World J Clin Oncol. 2017;8(3):190.
Mattar RE. Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol. 2016;22(2):567.
van Dam RM, Lodewick TM, van den Broek MAJ, de Jong MC, Greve JW, Jansen RLH, et al. Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases. HPB. 2014;16(6):550–9.
Al Bandar MH, Kim NK. Current status and future perspectives on treatment of liver metastasis in colorectal cancer. Oncol Rep. 2017;37(5):2553–64.
Ksienski D, Woods R, Speers C, Kennecke H. Patterns of referral and resection among patients with liver-only metastatic colorectal cancer (MCRC). Ann Surg Oncol. 2010;17(12):3085–93.
Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al. Hepatic Insufficiency and Mortality in 1,059 Noncirrhotic Patients Undergoing Major Hepatectomy. J Am Coll Surg. 2007;204(5):854–62.
Asencio JM, García Sabrido JL, Olmedilla L. How to expand the safe limits in hepatic resections? J Hepato-Biliary-Pancreat Sci. 2014;21(6):399–404.
Asencio JM, Vaquero J, Olmedilla L, García Sabrido JL. “Small-for-flow” syndrome: Shifting the “size” paradigm. Med Hypotheses. 2013;80(5):573–7.
Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Wallis Marsh J, Tom K, et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome: Am J Surg Pathol. 2006;30(8):986–93.
Xiang L, Huang L, Wang X, Zhao Y, Liu Y, Tan J. How much portal vein flow is too much for liver remnant in a stable porcine model? Transplant Proc enero de 2016;48(1):234–41.
Asencio J, Steiner M, García-Sabrido J, López-Baena JA, Ferreiroa J, Morales A, et al. Early changes in small-for-flow syndrome: an experimental model. J Liver Dis Transplant. 2013;03(01).
Golriz M, Majlesara A, El Sakka S, Ashrafi M, Arwin J, Fard N, et al. Small for Size and Flow (SFSF) syndrome: An alternative description for posthepatectomy liver failure. Clin Res Hepatol Gastroenterol. 2016;40(3):267–75.
Yagi S, Iida T, Taniguchi K, Hori T, Hamada T, Fujii K, et al. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl enero de 2005;11(1):68–75.
Orue-Echebarria MI, Vaquero J, Lisbona CJ, Lozano P, Steiner MA, Morales Á, et al. Comprehensive Characterization of a Porcine Model of The “Small-for-Flow” Syndrome. J Gastrointest Surg. 2019;23(11):2174–83.
Lafaro K, Buettner S, Maqsood H, Wagner D, Bagante F, Spolverato G, et al. Defining Post Hepatectomy Liver Insufficiency: Where do We stand? J Gastrointest Surg 2015;19(11):2079–92.
Allard M-A, Adam R, Bucur P-O, Termos S, Cunha AS, Bismuth H, et al. Posthepatectomy portal vein pressure predicts liver failure and mortality after major liver resection on noncirrhotic liver: Ann Surg. noviembre de 2013;258(5):822–30.
Eshkenazy R, Dreznik Y, Lahat E, Zakai BB, Zendel A, Ariche A. Small for size liver remnant following resection: prevention and management. HepatoBiliary Surg Nutr. 2014;3(5):10.
Alizai PH, Haelsig A, Bruners P, Ulmer F, Klink CD, Dejong CHC, et al. Impact of liver volume and liver function on posthepatectomy liver failure after portal vein embolization– A multivariable cohort analysis. Ann Med Surg. 2018;25:6–11.
Kohler A, Moller PW, Frey S, Tinguely P, Candinas D, Obrist D, et al. Portal hyperperfusion after major liver resection and associated sinusoidal damage is a therapeutic target to protect the remnant liver. Am J Physiol-Gastrointest Liver Physiol. 1 de septiembre de 2019;317(3):G264–74.
Wang X-Q. Portal inflow preservation during portal diversion in small-for-size syndrome. World J Gastroenterol. 2014;20(4):1021.
Carrapita JG, Rocha C, Donato H, Costa A, Abrantes AM, Santos JN, et al. Portal venous pressure variation during hepatectomy: a prospective study. Acta Médica Port. 28 de junio de 2019;32(6):420.
Schwarz L, Faitot F, Soubrane O, Scatton O. Splenic artery ligation for severe oxaliplatin induced portal hypertension: A way to improve postoperative course and allow adjuvant chemotherapy for colorectal liver metastases. Eur J Surg Oncol EJSO junio de 2014;40(6):787–8.
Sato Y, Kobayashi T, Nakatsuka H, Yamamoto S, Oya H, Watanabe T, et al. Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis. Hepatogastroenterology 2001;48(39):831–5.
Rhaiem R, Piardi T, Chetboun M, Pessaux P, Lestra T, Memeo R, et al. Portal Inflow Modulation by Somatostatin After Major Liver Resection: A Pilot Study. Ann Surg junio de 2018;267(6):e101–3.
Famularo S, Nefotyou K, Fotiadis N, Khan N, Foxton M, Khan AZ. Small-for-Size Liver Syndrome: a Case Series with a Proposal for Management Based on Portal Flow Modulation. J Gastrointest Cancer junio de 2015;46(2):185–9.
Treska V. Methods to Increase Future Liver Remnant Volume in Patients with Primarily Unresectable Colorectal Liver Metastases: Current State and Future Perspectives. Anticancer Res 2016;36(5):2065–72.
Hwang S, Lee S-G, Ko G-Y, Kim B-S, Sung K-B, Kim M-H, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy: Ann Surg. 2009;249(4):608–16.
Le Roy B, Dupré A, Gallon A, Chabrot P, Gagnière J, Buc E. Liver hypertrophy: Underlying mechanisms and promoting procedures before major hepatectomy. J Visc Surg 2018;155(5):393–401.
Olthof PB, Schnitzbauer AA, Schadde E. The HPB controversy of the decade: 2007–2017 – Ten years of ALPPS. Eur J Surg Oncol 2018;44(10):1624–7.
Nagano Y, Nagahori K, Kamiyama M, Fujii Y, Kubota T, Endo I, et al. Improved functional reserve of hypertrophied contra lateral liver after portal vein ligation in rats. J Hepatol 2002;37(1):72–7.
Pardee A. G1 events and regulation of cell proliferation. Science 1989;246(4930):603–8.
Asencio JM, García-Sabrido JL, López-Baena JA, Olmedilla L, Peligros I, Lozano P, et al. Preconditioning by portal vein embolization modulates hepatic hemodynamics and improves liver function in pigs with extended hepatectomy. Surgery. 2017;161(6):1489–501.
Lozano P, Martín L, Orue-Echebarria M, Asencio JM, Sharma H, López-Baena JA. Purpose of the measurement of intraoperative hepatic hemodynamics in liver transplant surgery. Arch Organ Transplant. 22 de marzo de 2019;001–4.
Bogner A, Reissfelder C, Striebel F, Mehrabi A, Ghamarnejad O, Rahbari M, et al. Intraoperative Increase of Portal Venous Pressure is an Immediate Predictor of Posthepatectomy Liver Failure After Major Hepatectomy: A Prospective Study. Ann Surg. 2019;Epub ahead of print.
Smyrniotis VE, Kostopanagiotou G, Theodoraki K, Gamaletsos E, Kondi-Pafiti A, Mystakidou K, et al. Effect of mesocaval shunt on survival of small-for-size liver grafts: experimental study in pigs: Transplantation. mayo de 2003;75(10):1737–40.
Kelly DM, Zhu X, Shiba H, Irefin S, Trenti L, Cocieru A, et al. Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small-for-size syndrome. Liver Transpl. noviembre de 2009;15(11):1448–57.
Ladurner R, Schenk M, Margreiter R, Offner F, Königsrainer A. Influence of Portosystemic Shunt on Liver Regeneration after Hepatic Resection in Pigs. HPB Surg. 2009;2009:1–8.
Di Domenico S, Santori G, Traverso N, Balbis E, Furfaro A, Grillo F, et al. Early effects of portal flow modulation after extended liver resection in rat. Dig Liver Dis. octubre de 2011;43(10):814–22.
Wang D-D, Xu Y, Zhu Z-M, Tan X-L, Tu Y-L, Han M-M, et al. Should temporary extracorporeal continuous portal diversion replace meso/porta-caval shunts in “small-for-size” syndrome in porcine hepatectomy? World J Gastroenterol. 2015;21(3):888.
Mohkam K, Darnis B, Schmitt Z, Duperret S, Ducerf C, Mabrut J-Y. Successful modulation of portal inflow by somatostatin in a porcine model of small-for-size syndrome. Am J Surg. 2016;212(2):321–6.
Carrapita J, Abrantes AM, Campelos S, Gonçalves AC, Cardoso D, Sarmento-Ribeiro AB, et al. Impact of splenic artery ligation after major hepatectomy on liver function, regeneration and viability. Sci Rep. diciembre de 2016;6(1):34731.
Bucur PO, Bekheit M, Audebert C, Othman A, Hammad S, Sebagh M, et al. Modulating Portal Hemodynamics With Vascular Ring Allows Efficient Regeneration After Partial Hepatectomy in a Porcine Model: Ann Surg. febrero de 2017;1.
Athanasiou A, Papalois A, Kontos M, Griniatsos J, Liakopoulos D, Spartalis E, et al. The beneficial role of simultaneous splenectomy after extended hepatectomy: experimental study in pigs. J Surg Res. febrero de 2017;208:121–31.
Song Z, Humar B, Gupta A, Maurizio E, Borgeaud N, Graf R, et al. Exogenous melatonin protects small-for-size liver grafts by promoting monocyte infiltration and releases interleukin-6. J Pineal Res. agosto de 2018;65(1):e12486.
Takamatsu Y, Hori T, Machimoto T, Hata T, Kadokawa Y, Ito T, et al. Intentional Modulation of Portal Venous Pressure by Splenectomy Saves the Patient with Liver Failure and Portal Hypertension After Major Hepatectomy: Is Delayed Splenectomy an Acceptable Therapeutic Option for Secondary Portal Hypertension? Am J Case Rep. 7 de febrero de 2018;19:137–44.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Orue-Echebarria, M.I., Lozano, P., Olmedilla, L. et al. “Small-for-Flow” Syndrome: Concept Evolution. J Gastrointest Surg 24, 1386–1391 (2020). https://doi.org/10.1007/s11605-020-04576-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-020-04576-9